News

The prefilled, patient-ready-to-use system is said to support delivery of high-viscosity biologics of up to 50 centipoise.
Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...
BD has found a new home for its biosciences and diagnostics divisions at the lab equipment maker Waters Corporation, through ...
Waters and BD will merge biosciences and diagnostics in a $17.5B deal via Reverse Morris Trust, creating a life sciences ...
Becton Dickinson (BDX) announced the first pharma-sponsored combination product clinical trial using the BD Libertas Wearable Injector for ...
The BD business will be spun off and merged with a Waters subsidiary. Waters shares were down about 11% in early trading ...
BD has picked a new executive to lead its planned connected care segment, as the company nears the conclusion of its ...